基因组规模的转录激活由一个工程 CRISPR-Cas9 复合体
Silvana Konermann1, Mark D Brigham1, Alexandro E Trevino1
11] Broad Institute of MIT and Harvard, 75 Ames Street, Cambridge, Massachusetts 02142, USA [2] McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA [3] Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA [4] Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Nature
|December 11, 2014
概括
工程CRISPR-Cas9激活器使得功能研究的基因表达精确控制. 这项技术使大规模的屏幕能够识别赋予药物耐药性的基因,从而推动了基因扰乱研究.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 强大的基因表达扰动对于理解基因功能至关重要.
- 克里斯普尔-Cas9技术为基因操纵提供了一个强大的平台.
研究的目的:
- 设计一个CRISPR-Cas9复合体,以在内生基因组位点进行高效的转录激活.
- 为了研究转录激活的单导向RNA (sgRNA) 向规则.
- 选激活后对BRAF抑制剂产生抗性的基因.
主要方法:
- 用于转录激活的CRISPR-Cas9复合体的结构引导工程.
- 利用工程 Cas9 激活复合体来研究 sgRNA 向规则.
- 执行多重基因激活和高调长跨基因非编码RNA (lincRNA) 转录.
- 合成了大量的指南库,用于针对BRAF抑制剂耐药性的全基因组屏幕.
主要成果:
- 通过使用工程 Cas9 激活器,在内源基位表现出高效的转录激活.
- 确定了有效转录激活的sgRNA向规则.
- 成功实现了十个基因的多重激活和上调的lincRNA转录.
- 发现了已知和新型基因,通过大规模屏幕赋予BRAF抑制剂耐药性.
- 验证了查结果,并发现了与BRAF抑制剂耐药性相关的基因表达特征.
结论:
- 工程 Cas9 激活器代表了一种用于基因扰乱的强大技术.
- 这种方法可以实现高效的转录激活和大规模的功能性基因组屏幕.
- 这些发现对理解耐药性机制和开发新的治疗策略具有重要意义.
相关概念视频
CRISPR/Cas9 Genome Editing
2.3K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.3K
CRISPR
58.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.5K
CRISPR and crRNAs
19.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.4K
Homologous Recombination
64.8K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
64.8K


